anonymous
Guest
anonymous
Guest
Don’t get too comfortable. Layoffs have started.
with what division? Positions affected?
Don’t get too comfortable. Layoffs have started.
Xeljanz, Derm, BioSimilar, Rara Disease, Hospitalswith what division? Positions affected?
It has already been decidedJust wait till the dust settles and Pfizer makes changes to adapt to new norm. I predict huge layoffs which they spin as “ rightsizing”
Vaccineswith what division? Positions affected?
It made no sense for Cluster 1&3 to remain so large after the last reduction. It's possible that management was trying to save as many DM positions as they could. But, CW and Ian are gone. Chantix patent expires this year. How are those positions justified? Certainly not with Eucrisa and Cologuard.In this environment why would they cut vaccines?
Cluster 2 has a co-promote with BMS and call numbers to meet.
Cluster 1 and 3 has the redundancy.
All depends on Tanny... it’s still tracking for Dec approval right? It may just work out.It made no sense for Cluster 1&3 to remain so large after the last reduction. It's possible that management was trying to save as many DM positions as they could. But, CW and Ian are gone. Chantix patent expires this year. How are those positions justified? Certainly not with Eucrisa and Cologuard.
I would say no. This will fall primarily in the hands of pain specialists, emergency room, and perhaps orthowill pc doctors really prescribe an injectable pain drug?
This is the most accurate postVaccines
Xeljanz
Derm
Biosimilars
Rare Disease
Cluster 2
Hospital
Heard only Oncology will be untouched due to recent acquisitions w attrition .
All division depending on currently 1 or 2 rep territories will be 25-60% cuts
This is the most accurate post
no she said cluster 2, thats the LEAST likely team to have any layoffs.